Clinical Trial Update: Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding [NA]

View source ↗

Summary

A completed clinical trial evaluated valacyclovir for reducing recurrence and shedding of HSV-2, including HIV-infected participants, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes
• HIV Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: HIV, HIV Infections | NA | Status: COMPLETED | Results posted: 2017-07-13